Title : Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.

Pub. Date : 2020 May 27

PMID : 32471250






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens